Intrathecal IgG synthesis: a resistant and valuable target for future multiple sclerosis treatments. Bonnan M Mult Scler Int. 2015; 2015:296184. Epub 2015 Jan 08. PMID: 25653878. Abstract CommentRecommendBookmarkWatch